×
About 17,068 results

ALLMedicine™ Vasculitis Center

Research & Reviews  5,998 results

An Unusual Case of Stroke as the Initial Manifestation of Early Takayasu Arteritis with...
https://doi.org/10.12659/AJCR.936321
The American Journal of Case Reports; Chiew YR, Seet YHC

May 20th, 2022 - BACKGROUND Takayasu arteritis is a rare systemic inflammatory vasculitis of granulomatous nature. The etiology of Takayasu arteritis is still unknown and it affects the aorta and its main branches. Takayasu arteritis is more common in Asians and w...

Severe Bartonella henselae bone infection in a kidney transplanted young man.
https://doi.org/10.1136/bcr-2021-247805
BMJ Case Reports; Christensen HD, Madelung AB et. al.

May 19th, 2022 - We present a case of a young kidney transplanted man. He was admitted with lymphadenopathy, fluctuating fever and night sweats 2 months after a cat bite. After admission, he developed severe pain around his right hip. An 18F-fluorodeoxyglucose (FD...

SAMHD1 associates with inflammation and vasculitis in paediatric-onset systemic lupus e...
https://doi.org/10.55563/clinexprheumatol/4k3gau
Clinical and Experimental Rheumatology; Zhao X, Li C et. al.

May 18th, 2022 - In this study, we aimed to explore the expression of the Aicardi-Goutières syndrome (AGS) mutant gene SAMHD1 in paediatric-onset systemic lupus erythematosus (pSLE), its correlations with clinical and laboratory parameters, and the relationship be...

Rare presentation of eosinophilic granulomatosis polyangiitis with left ventricular end...
https://doi.org/10.1017/S104795112200155X
Cardiology in the Young; Doraiswamy V, Vengudusamy S et. al.

May 17th, 2022 - Eosinophilic granulomatosis polyangiitis represents less than 2% of vasculitis cases in childhood. Children have worse long-term outcomes and higher mortality. Cardiac involvement portends a worse prognosis. We describe here an adolescent girl who...

Cutaneous manifestations of ANCA-associated vasculitis: a retrospective review of 211 c...
https://doi.org/10.1111/ijd.16214
International Journal of Dermatology; Shakshouk H, Gibson LE

May 17th, 2022 - ANCA-associated vasculitis (AAV) may present a wide array of dermatological manifestations. Patients may remain ANCA negative, rendering diagnosis challenging for dermatologists if they depend heavily on ANCA testing to either confirm or rule out ...

see more →

Guidelines  22 results

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease
https://www.rheumatology.org/Portals/0/Files/Guideline-Management-Kawasaki-Disease.pdf
American College of Rheumatology; Gorelik M, .

Mar 8th, 2022 - Kawasaki disease (KD) is a medium vessel vasculitis as presented in the Chapel Hill Consensus Conference nomenclature system (1). It is 1 of 2 primary common vasculitis syndromes that predominantly affect children (the other being IgA vasculitis...

Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis:...
https://doi.org/10.1136/bmj-2021-064597
BMJ (Clinical Research Ed.); Zeng L, Walsh M et. al.

Feb 27th, 2022 - What is the role of plasma exchange and what is the optimal dose of glucocorticoids in the first 6 months of therapy of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)? This guideline was triggered by the publi...

2022 American College of Rheumatology/European Alliance of Associations for Rheumatolog...
https://doi.org/10.1002/art.41982
Arthritis & Rheumatology (Hoboken, N.J.); Grayson PC, Ponte C et. al.

Feb 3rd, 2022 - To develop and validate revised classification criteria for eosinophilic granulomatosis with polyangiitis (EGPA). Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 5 phases: 1) iden...

2022 American College of Rheumatology/European Alliance of Associations for Rheumatolog...
https://doi.org/10.1002/art.41986
Arthritis & Rheumatology (Hoboken, N.J.); Robson JC, Grayson PC et. al.

Feb 3rd, 2022 - To develop and validate revised classification criteria for granulomatosis with polyangiitis (GPA). Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 5 phases: 1) identification of ...

2022 American College of Rheumatology/European Alliance of Associations for Rheumatolog...
https://doi.org/10.1002/art.41983
Arthritis & Rheumatology (Hoboken, N.J.); Suppiah R, Robson JC et. al.

Feb 3rd, 2022 - To develop and validate classification criteria for microscopic polyangiitis (MPA). Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 5 phases: 1) identification of candidate items ...

see more →

Drugs  157 results see all →

Clinicaltrials.gov  98 results

The Pathogenesis and Natural History of Sjogren s Syndrome
https://clinicaltrials.gov/ct2/show/NCT01425892

May 13th, 2022 - BACKGROUND Sj(SqrRoot)(Delta)gren s syndrome (SS) is an autoimmune disease characterized by chronic inflammation involving the exocrine glands. Salivary and lacrimal glands are predominantly affected leading to dry mouth and dry eyes but other exo...

Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
https://clinicaltrials.gov/ct2/show/NCT02257866

May 13th, 2022 - The purpose of this protocol is to study the natural history of idiopathic systemic vasculitis in children and adults. The idiopathic vasculitides are a group of rare, systemic diseases involving inflammation of arteries and other tissue with resu...

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
https://clinicaltrials.gov/ct2/show/NCT05003986

May 11th, 2022 - This is a multicenter, open-label, 108-week study of sparsentan in approximately 57 pediatric subjects aged ≥1 year to <18 years with selected proteinuric glomerular diseases, divided into 2 populations, defined as follows: Population 1: Subjects ...

Efficacy and Safety of Partial Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis
https://clinicaltrials.gov/ct2/show/NCT05197842

May 5th, 2022 - The aim of the trial is to study the efficacy and safety of treatment with BDB-001 Injection partial substitution of glucocorticoid in patients with ANCA-associated vasculitis.

Zooming in on Cerebral Abnormalities in Severely Affected COVID-19 Patients
https://clinicaltrials.gov/ct2/show/NCT05197296

Apr 8th, 2022 - Brain injury is one of the complications in COVID-19 intensive care unit (ICU) survivors, though the precise underlying mechanism is unclear. It is likely caused by a combination of prolonged hypoxia, a massive systemic inflammatory response, dire...

see more →

News  538 results

Granuloma Faciale in Woman With Levamisole-Induced Vasculitis
https://www.mdedge.com/dermatology/article/254112/dermatopathology/granuloma-faciale-woman-levamisole-induced-vasculitis
Ruby Gibson, MD, Valerie Shiu, MD et. al.

Apr 26th, 2022 - To the Editor: A 53-year-old Hispanic woman presented to our dermatology clinic for evaluation of an expanding plaque on the right cheek of 2 months’ duration. The patient stated the plaque began as a pimple, which she picked with subsequent sprea.

Kawasaki Disease Guideline Highlights Rheumatology Angles
https://www.medscape.com/viewarticle/970815

Mar 23rd, 2022 - All Kawasaki disease (KD) patients should be treated first with intravenous immunoglobulin, according to an updated guideline issued jointly by the American College of Rheumatology and the Vasculitis Foundation. Dr Mark Gorelik KD has low mortalit...

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease
https://www.rheumatology.org/Portals/0/Files/Guideline-Management-Kawasaki-Disease.pdf
American College of Rheumatology; Gorelik M, .

Mar 8th, 2022 - Kawasaki disease (KD) is a medium vessel vasculitis as presented in the Chapel Hill Consensus Conference nomenclature system (1). It is 1 of 2 primary common vasculitis syndromes that predominantly affect children (the other being IgA vasculitis...

Plasma Exchange Works for ANCA-Associated Vasculitis
https://www.medscape.com/viewarticle/969671

Mar 8th, 2022 - NEW YORK (Reuters Health) - Plasma exchange can be an effective treatment for anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV), according to an updated systematic review and meta-analysis. Granulomatosis with polyangiitis and ...

Avacopan Shows Efficacy Signal for Rare Kidney Disease, C3G
https://www.medscape.com/viewarticle/969740

Mar 7th, 2022 - Avacopan, recently approved by the US Food and Drug Administration (FDA) for adjunctive treatment of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, showed a significant benefit in C3 glomerulopathy (C3G) by reducing the dise...

see more →

Patient Education  14 results see all →